Question
How did prosecutors choose which victims testified at Maxwell’s trial?
Answer
Federal prosecution in complex trafficking cases involves significant strategic decisions about which witnesses will testify at trial. In the Maxwell case, prosecutors from the Southern District of New York had a larger pool of potential victim-witnesses to draw from than the four who ultimately testified.
Key criteria prosecutors typically apply:
Corroboration: Prosecutors prefer victims whose accounts are supported by independent corroborating evidence — flight logs, physical evidence, witness confirmation, prior consistent statements. Victims with strong corroboration are harder for the defense to discredit.
Temporal and jurisdictional scope: The Maxwell indictment covered specific time periods and geographic locations. Victims whose experiences fell within those parameters and involved Maxwell’s specific conduct were more directly relevant to the charged conduct.
Victim willingness: Testifying at trial is traumatic and invasive. Prosecutors can only work with victims who are willing to endure cross-examination, public attention (even in pseudonymous form), and the stress of courtroom proceedings. Many victims understandably decline.
Defense exposure: Prosecutors assess the vulnerability of each victim’s account to cross-examination. A victim with heavily documented inconsistencies in prior statements creates more risk than one with a consistent record.
The four ultimate witnesses — Carolyn, Jane, Kate, and Annie Farmer — provided complementary testimony that covered different properties, time periods, and aspects of Maxwell’s conduct. Together, they established a pattern sufficient for the jury’s guilty verdict on five counts.
Victims who were not selected to testify at trial may have participated in other ways: JEVCP claims, civil litigation, depositions, or grand jury proceedings.
Sources
Maxwell trial strategy analysis; prosecution witness selection discussion in court briefs; journalism on victim advocacy through the proceedings; trial outcome analysis.